HU167748B - - Google Patents

Info

Publication number
HU167748B
HU167748B HUEI532A HUEI000532A HU167748B HU 167748 B HU167748 B HU 167748B HU EI532 A HUEI532 A HU EI532A HU EI000532 A HUEI000532 A HU EI000532A HU 167748 B HU167748 B HU 167748B
Authority
HU
Hungary
Application number
HUEI532A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU167748B publication Critical patent/HU167748B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HUEI532A 1974-02-06 1974-03-07 HU167748B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US439206A US3926978A (en) 1974-02-06 1974-02-06 Process for preparing 3-fluorocephalosporins

Publications (1)

Publication Number Publication Date
HU167748B true HU167748B (en:Method) 1975-12-25

Family

ID=23743733

Family Applications (1)

Application Number Title Priority Date Filing Date
HUEI532A HU167748B (en:Method) 1974-02-06 1974-03-07

Country Status (32)

Country Link
US (1) US3926978A (en:Method)
JP (1) JPS612678B2 (en:Method)
AR (1) AR202209A1 (en:Method)
AT (1) AT329181B (en:Method)
BE (1) BE813169A (en:Method)
BG (1) BG25091A3 (en:Method)
BR (1) BR7404085A (en:Method)
CA (1) CA1017741A (en:Method)
CH (1) CH598263A5 (en:Method)
DD (1) DD117465A5 (en:Method)
DE (1) DE2417988A1 (en:Method)
DK (1) DK119874A (en:Method)
EG (1) EG11061A (en:Method)
ES (1) ES427235A1 (en:Method)
FI (1) FI99474A7 (en:Method)
FR (1) FR2259826B1 (en:Method)
GB (1) GB1462944A (en:Method)
GT (1) GT197432532A (en:Method)
HU (1) HU167748B (en:Method)
IE (1) IE38980B1 (en:Method)
IL (1) IL44361A (en:Method)
IN (1) IN139927B (en:Method)
MW (1) MW1074A1 (en:Method)
NL (1) NL7403126A (en:Method)
NO (1) NO741093L (en:Method)
OA (1) OA04641A (en:Method)
PH (1) PH12616A (en:Method)
PL (1) PL90989B1 (en:Method)
RO (1) RO63021A (en:Method)
SE (1) SE411453B (en:Method)
ZA (1) ZA741423B (en:Method)
ZM (1) ZM5674A1 (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208515A (en) * 1973-02-23 1980-06-17 Eli Lilly And Company 3-Halo cephalosporins
US4064343A (en) * 1974-04-01 1977-12-20 Eli Lilly And Company 3-Halo cephalosporins
US4281116A (en) * 1979-10-12 1981-07-28 Eli Lilly And Company 3-Halo cephalosporins
US4252950A (en) * 1979-10-12 1981-02-24 Eli Lilly And Company 3-Halo cephalosporins
US4260745A (en) * 1979-10-12 1981-04-07 Eli Lilly And Company 3-Halo cephalosporins
ATE111468T1 (de) * 1987-02-27 1994-09-15 Banyu Pharma Co Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und antibakterielle mittel.
JPH0343723A (ja) * 1989-07-11 1991-02-25 Japan Servo Co Ltd 投影器
WO1993011132A1 (de) * 1991-12-06 1993-06-10 Ciba-Geigy Ag Verfahren zur herstellung des antibiotikums cefaclor
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati
US8372000B2 (en) 2007-01-03 2013-02-12 Boston Scientific Scimed, Inc. Method and apparatus for biliary access and stone retrieval

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830808A (en) * 1968-06-14 1974-08-20 Glaxo Lab Ltd Cephalosporins having a thioetherified methyl group at the 3-position
GB1377651A (en) * 1971-01-12 1974-12-18 Glaxo Lab Ltd Esters

Also Published As

Publication number Publication date
DE2417988A1 (de) 1975-08-07
AR202209A1 (es) 1975-05-23
JPS612678B2 (en:Method) 1986-01-27
US3926978A (en) 1975-12-16
NL7403126A (nl) 1975-08-08
GB1462944A (en) 1977-01-26
CA1017741A (en) 1977-09-20
BG25091A3 (bg) 1978-07-12
AU6640374A (en) 1975-09-11
ZM5674A1 (en) 1977-04-21
FI99474A7 (en:Method) 1975-08-07
OA04641A (fr) 1980-07-31
FR2259826B1 (en:Method) 1977-06-24
IL44361A0 (en) 1974-06-30
IN139927B (en:Method) 1976-08-21
BE813169A (fr) 1974-10-02
JPS50108287A (en:Method) 1975-08-26
EG11061A (en) 1976-11-30
CH598263A5 (en:Method) 1978-04-28
IL44361A (en) 1977-07-31
AT329181B (de) 1976-04-26
DD117465A5 (en:Method) 1976-01-12
ZA741423B (en) 1975-10-29
DK119874A (en:Method) 1975-09-29
ES427235A1 (es) 1976-07-16
SE411453B (sv) 1979-12-27
ATA312174A (de) 1975-07-15
NO741093L (en:Method) 1975-09-01
MW1074A1 (en) 1975-07-09
IE38980B1 (en) 1978-07-05
SE7403307L (en:Method) 1975-08-07
RO63021A (fr) 1978-05-15
IE38980L (en) 1975-08-06
FR2259826A1 (en:Method) 1975-08-29
PH12616A (en) 1979-07-05
PL90989B1 (en:Method) 1977-02-28
GT197432532A (es) 1975-09-25
BR7404085A (pt) 1976-01-27

Similar Documents

Publication Publication Date Title
FI751931A7 (en:Method)
FI751387A7 (en:Method)
FR2259826B1 (en:Method)
FI751721A7 (en:Method)
FI750606A7 (en:Method)
FR2260842B1 (en:Method)
FR2281436B3 (en:Method)
FR2296324B1 (en:Method)
CS177969B1 (en:Method)
CS174511B1 (en:Method)
CS173961B1 (en:Method)
CS169270B1 (en:Method)
CS173904B1 (en:Method)
CS175850B1 (en:Method)
CS175073B1 (en:Method)
DD113846A1 (en:Method)
DD112549A5 (en:Method)
CH599632A5 (en:Method)
CH613016A5 (en:Method)
CH586113A5 (en:Method)
CH596671A5 (en:Method)
CH583410A5 (en:Method)
CH578340A5 (en:Method)
CH585897A5 (en:Method)
CH575486A5 (en:Method)